Rationale and aimDiaphragm dysfunction is common in severe emphysema patients, primarily due to hyperinflation, placing the diaphragm at a mechanical disadvantage. Endobronchial valve (EBV) treatment is a bronchoscopic procedure to reduce hyperinflation, and thus potentially restore diaphragm function in this patient population. Our aim was to investigate the effect of EBV treatment on diaphragm function.Patients and methodsA prospective cohort study was performed in which diaphragm function was measured at baseline and 6 weeks after EBV treatment by ultrasonic assessment to measure diaphragm motion and diaphragm thickening fraction (dTF), surface electromyography (sEMG) to quantify diaphragm activity, and maximal inspiratory pressure (MIP) to assess diaphragm strength.ResultsTwenty-five patients were included, with a mean age of 64±7 years. Residual volume (−0.85±0.49 Liter, p<0.001) decreased significantly post EBV treatment, with a significant increase in MIP (+0.6 kPa, range −1.2–2.8, p=0.001). Diaphragm motion on the treated side during tidal breathing significantly decreased (−3.3 mm, range −24.7–14.6, p=0.023). There were no significant changes in dTF on the treated side. Diaphragm activity (sEMG) for tidal breathing (−1.7 µV, p=0.004, range −8.8–5.8), maximal inspiration (−4.1 µV, p=0.004, range −42.3–16.0), and sniff manoeuvre (−6.1 µV, p=0.027, range −42.2–24.2) all significantly decreased.ConclusionOur results show that diaphragm function significantly improves after EBV treatment in severe emphysema patients. This emphasizes the physiological interaction between hyperinflation and diaphragm function, suggesting that reducing hyperinflation can at least partially reverse diaphragm dysfunction.
Read full abstract